Differential responses to vitamin D2 and Vitamin D3 Are Associated with variations in free 25-Hydroxyvitamin D

Endocrinology

Volumn 157, Issue 9, 2016, Pages 3420-3430

  Chun, Rene F ^a   Hernandez, Ivan ^c   Pereira, Renata ^b   Swinkles, Leon ^e   Huijs, Tonnie ^e   Zhou, Rui ^a   Liu, Nancy Q ^a   Shieh, Albert ^a   Guemes, Miriam ^b   Mallya, Sanjay M ^b   Adams, John S ^a   Hewison, Martin ^a,c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UCLA SCHOOL OF DENTISTRY   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Birmingham Women s Hospital NHS Foundation Trust   (United Kingdom)

^e Future Diagnostics Solutions   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25 HYDROXYVITAMIN D 1ALPHA HYDROXYLASE; CALCITRIOL; CD11B ANTIGEN; CD14 ANTIGEN; COLECALCIFEROL; ERGOCALCIFEROL; MINERAL; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VITAMIN D 24 HYDROXYLASE; VITAMIN D RECEPTOR; 25-HYDROXYVITAMIN D; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BONE MASS; BONE STRUCTURE; CELL COMPOSITION; CIRCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOMETRY; PHENOTYPIC VARIATION; PLASMA HALF LIFE; PRIORITY JOURNAL; TRABECULAR BONE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WEANING; ANALOGS AND DERIVATIVES; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; BONE; C57BL MOUSE; CELL LINE; KIDNEY; METABOLISM; SPLEEN;

ANIMALS; BONE AND BONES; CELL LINE; CHOLECALCIFEROL; ERGOCALCIFEROLS; FEMALE; HUMANS; KIDNEY; MALE; MICE, INBRED C57BL; SPLEEN; VITAMIN D;

EID: 84985905657     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2016-1139     Document Type: Article

References (42)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357:266- 281.
2. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol. 2009;19:73-78.
3. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. J Clin Endocrinol Metab. 2011;96:53-58.
4. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96:1911-1930.
5. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab. 2008;4:80-90.
6. Carlberg C, Seuter S. A genomic perspective on vitaminDsignaling. Anticancer Res. 2009;29:3485-3493.
7. Spina CS, Tangpricha V, Uskokovic M, Adorinic L, Maehr H, Holick MF. Vitamin D and cancer. Anticancer Res. 2006;26:2515- 2524.
8. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr. 2004;79:362-371.
9. Hewison M. Vitamin D and immune function: Autocrine, paracrine or endocrine? Scand J Clin Lab Invest Suppl. 2012;243:92-102.
10. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG. Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab. 1986;63:954-959.
11. Bikle DD, Gee E, Halloran B, Haddad JG. Free 1, 25-dihydroxyvitaminDlevels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984;74:1966-1971.
12. Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999;96:507-515.
13. Nykjaer A, Fyfe JC, Kozyraki R, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci USA. 2001;98:13895-13900.
14. Bouillon R, Van Assche FA, Van Baelen H, Heyns W, De Moor P. Influence of the vitamin D-binding protein on the serum concentration of 1, 25-dihydroxyvitamin D3: significance of the free 1, 25- dihydroxyvitamin D3 concentration. J Clin Invest. 1981;67:589- 596.
15. Zehnder D, Bland R, Williams MC, et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1-hydroxylase. J Clin Endocrinol Metab. 2001;86:888-894.
16. Chun RF, Lauridsen AL, Suon L, et al. Vitamin D-binding protein directs monocyte responses to 25-hydroxy- And 1, 25-dihydroxyvitamin D. J Clin Endocrinol Metab. 2010;95:3368-3376.
17. Mendel CM. The free hormone hypothesis: A physiologically based mathematical model. Endocr Rev. 1989;10:232-274.
18. Hammond GL. Access of reproductive steroids to target tissues. Obstet Gynecol Clin North Am. 2002;29:411-423.
19. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DBP: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol. 2014;144(Pt A):132-137.
20. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet. 2010;376:180-188.
21. Safadi FF, Thornton P, Magiera H, et al. Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein. J Clin Invest. 1999;103:239-251.
22. Belsey R, Clark MB, Bernat M, et al. The physiologic significance of plasma transport of vitamin D and metabolites. Am J Med. 1974; 57:50-56.
23. Jones G, Byrnes B, Palma F, Segev D, Mazur Y. Displacement potency of vitamin D2 analogs in competitive protein-binding assays for 25-hydroxyvitamin D3, 24, 25-dihydroxyvitamin D3, and 1, 25- dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980;50:773-775.
24. Hollis BW. Comparison of equilibrium and disequilibrium assay conditions for ergocalciferol, cholecalciferol and their major metabolites. J Steroid Biochem. 1984;21:81-86.
25. Jones KS, Assar S, Harnpanich D, et al.25(OH)D2half-life is shorter than 25(OH)D3 half-life and is influenced by DBP concentration and genotype. J Clin Endocrinol Metab. 2014;99:3373-3381.
26. Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006;84:694-697.
27. Liu NQ, Ouyang Y, Bulut Y, et al. Dietary vitamin D restriction in pregnant female mice is associated with maternal hypertension and altered placental and fetal development. Endocrinology. 2013;154: 2270-2280.
28. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
29. Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25:1468-1486.
30. Zella LA, Shevde NK, Hollis BW, Cooke NE, Pike JW. Vitamin D-binding protein influences total circulating levels of 1, 25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology. 2008;149:3656-3667.
31. Tripkovic L, Lambert H, Hart K, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitaminDstatus: A systematic review and meta- Analysis.AmJ Clin Nutr. 2012;95:1357-1364.
32. Oliveri B, Mastaglia SR, Brito GM, et al. Vitamin D3 seems more appropriate than D2 to sustain adequate levels of 25OHD: A pharmacokinetic approach. Eur J Clin Nutr. 2015;69:697-702.
33. Hartwell D, Hassager C, Christiansen C. Effect of vitamin D2 and vitamin D3 on the serum concentrations of 1, 25(OH)2D2, and 1, 25(OH)2D3 in normal subjects. Acta Endocrinol. 1987;115:378- 384.
34. Glendenning P, Chew GT, Inderjeeth CA, Taranto M, Fraser WD. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol. Bone. 2013;56:271- 275.
35. Glatt V, Canalis E, Stadmeyer L, Bouxsein ML. Age-related changes in trabecular architecture differ in female and male C57BL/6J mice. J Bone Miner Res. 2007;22:1197-1207.
36. Nakamichi Y, Mizoguchi T, Arai A, et al. Spleen serves as a reservoir of osteoclast precursors through vitamin D-induced IL-34 expression in osteopetrotic op/op mice. Proc Natl Acad Sci USA. 2012; 109:10006-10011.
37. Powe CE, Ricciardi C, Berg AH, et al. Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res. 2011;26:1609-1616.
38. Bhan I, Powe CE, Berg AH, et al Bioavailable vitamin D is more tightly linked to mineral metabolism than total vitaminDin incident hemodialysis patients. Kidney Int. 2012;82:84-89.
39. Jemielita TO, Leonard MB, Baker J, et al. Association of 25-hydroxyvitaminDwith areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int. 2016;27(2):617-626.
40. Aloia J, Mikhail M, Dhaliwal R, et al. Free25(OH)Dand the vitamin D paradox in African Americans. J Clin Endocrinol Metab. 2015; 100:3356-3363.
41. Schwartz JB, Lai J, Lizaola B, et al. A comparison of measured and calculated free 25(OH) vitamin D levels in clinical populations. J Clin Endocrinol Metab. 2014;99:1631-1637.
42. Jeffery LE, Wood AM, Qureshi OS, et al. Availability of 25-hydroxyvitamin D3 to APCs controls the balance between regulatory and inflammatory T cell responses. J Immunol. 2012;189:5155- 5164.